Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지

Cost-Effectiveness Analysis of a Hyperlipidemia Mass Screening Program in Korea

성인 고지혈증 선별 검사의 비용-효과 분석

  • Cha, Yeon-Soon (Department of Preventive Medicine, University of Ulsan College of Medicine) ;
  • Khang, Young-Ho (Department of Preventive Medicine, University of Ulsan College of Medicine) ;
  • Lee, Moo-Song (Department of Preventive Medicine, University of Ulsan College of Medicine) ;
  • Kang, Wee-Chang (Department of Information and Statistics, Daejeon University) ;
  • Jeon, Sung-Hoon (Health Promotion Center, Asan Medical Center) ;
  • Kim, Kee-Lak (Health Promotion Center, Asan Medical Center) ;
  • Lee, Sang-Il (Department of Preventive Medicine, University of Ulsan College of Medicine)
  • 차연순 (울산대학교 의과대학 예방의학교실) ;
  • 강영호 (울산대학교 의과대학 예방의학교실) ;
  • 이무송 (울산대학교 의과대학 예방의학교실) ;
  • 강위창 (대전대학교 정보통계학과) ;
  • 전성훈 (서울아산병원 건강증진센타) ;
  • 김기락 (서울아산병원 건강증진센타) ;
  • 이상일 (울산대학교 의과대학 예방의학교실)
  • Published : 2002.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Until now, there have been no evidence-based guidelines produced for the mass screening of hyperlipidemia cases in Korea. This study was done to find the most efficient strategy for a hyperlipidemia-screening program among Korean adults, Method : Seven alternative strategies for hyperlipidemia screening were formulated and compared ir terms of cost-effectiveness. Cost and effectiveness were estimated from social perspectives and using a two-stage screening process (initial testing and additional testing for positives from the first test). A computerized database (based on persons who had visited a health promotion center in one teaching hospital for a routine health check-up) was used to determine the cost and the outcome of various strategies. Official data was used in calculating direct and indirect costs. Effectiveness was measured according to the number of persons who needed clinical intervention for hyperlipidemia. A stratified analysis, considering age group and sex, was then done. Sensitivity analyses, focusing on several uncertain parameters, were also done. Results : Of the seven test alternatives available, the most cost-effective strategy was a screening program, which consisted of an initial test of total cholesterol, high-density lipoprotein cholesterol and triglyceride. There was some variation in the rank of the cost-effectiveness ratios for the seven alternatives dependent on age group or gender. Conclusions : Current hyperlipidemia screening practice, for National Health Insurance beneficiaries, tests only the total cholesterol level with a cut-off value of 260mg/dl as an initial screening test. It is not the best strategy for cost-effectiveness, and should be modified. Different screening strategies taking age group and sex into account should be developed and used for the efficient mass screening of hyperlipidemia cases among Korean adults.

Keywords

References

  1. 통계청. 1998년 사망원인 통계 연보. 1999
  2. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152(7): 1490-1500 https://doi.org/10.1001/archinte.152.7.1490
  3. 의료보험관리공단. 피보험자 건강진단 분석. 1981, 1991, 1999
  4. 김정순. 한국인 허혈성 심질환의 사망률 및 유병률과 그 위험요인. 제14차 한국지질학회 추계 학술대회 초록집. 1999
  5. 보건복지부. 건강진단 실시 기준. 보건복지부 고시 제1999-45호. 1999
  6. National Cholesterol Education Program Expert Panel. Summary of the second report of the National Cholesterol Education Program Expert Panel on Detection. Evaluation. and Treatment of High Blood Cholesterol in Adult(Adult Treatment Panel II). JAMA 1993; 269(23): 3015-3023 https://doi.org/10.1001/jama.269.23.3015
  7. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years follow-up from the Framingham Study. lAMA 1987; 257(16): 2176-2180 https://doi.org/10.1001/jama.257.16.2176
  8. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. NEJM 1993; 328(5): 313-318 https://doi.org/10.1056/NEJM199302043280504
  9. 이정권. 종합건강진단의 문제점.가정의학회지 1993; 14(6): 295-301
  10. Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weistein MC. Cost-Effectiveness of Cholesterol Lowerinig Therapies according to Selected Patient Characteristics. Ann Intern Med 2000; 132: 769-779
  11. Berg JE. Screening for cardiovascular risk: cost-benefit considerations in a comparison total cholesterol measurements and two compound blood lipid indices. Journal of Cardiovascular Risk 1995; 2(5): 1287-1293
  12. Joven J, Vilelle E. Primary prevention of arteriosclerosis: cost-efficiency ratio in the determination of cholesterol. Medicina Clinica 1990; 94(9): 333-336[Spanish]
  13. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary prevention Study Group. NEJM 1995; 333(20): 1301-1307 https://doi.org/10.1056/NEJM199511163332001
  14. 한국보건사회 연구원. 국민건강조사, 1995
  15. 양봉민, 김진현, 이석연. 산업보건사업의 경제성 분석. 직업병 예방사업의 비용-편익 분석. 노동부, 1992
  16. 통계청. 1998 한국의 사회지표, 1999
  17. Weinstein MC. Principles of costeffective resource allocation in health care organizations. Int J Technology Assessment in Health Care 1990; 6: 93-105 https://doi.org/10.1017/S0266462300008953
  18. Drummond MF, O' Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. second edition, Oxford, Oxford University Press, 1997
  19. Kim JQ, Song JH, Cho HI, Park YB, Lee HK, Tchai BS, Kim SI. References(cut-off) values for serum total cholesterol among Korean adults resident in Seoul. J Korean Med Assoc 1990; 33(12): 1338-1344[Korean]
  20. Goldman L, Gordon DJ, Rifkind BM. Cost and health implications of cholesterol lowering. Circulation 1992; 85: 1960-1968 https://doi.org/10.1161/01.CIR.85.5.1960
  21. Hully SB, Newman TB, Grady D, Garber AM, Baron RB, Browner WS. Should we be measuring blood cholesterol levels in young adults? JAMA 1993; 269(11): 1416-1419 https://doi.org/10.1001/jama.1993.03500110084041